Company Profile
Xinix Global AB, a Swedish firm established in 1992, has long specialised in the advancement of chlorine dioxide (ClO₂) products for water and surface disinfection. While ClO₂ has been utilised in gas form by industries and waterworks since the 1930s, Xinix now offers it in liquid form, accessible to all. Their FreeBact® range provides dependable protection, effectively neutralising viruses and bacteria such as E-Coli, Legionella, and Salmonella, with minimal plastic waste. Today, their solutions are trusted by leading companies, authorities, aid organisations, survivalists, adventurers, and private individuals across the globe.
Approach to Healthcare
One of the primary challenges in UK healthcare is ensuring effective disinfection. Daily, lives are at risk due to inadequate sanitation practices.
Key areas of concern include:
• The disinfection of hospital surfaces, medical instruments, and equipment.
• Personal hygiene and disinfection for both patients and staff.
• Safeguarding water systems, pipes, and tanks in healthcare facilities.
Xinix products offer proven solutions, delivering superior disinfection results, reduced costs, and ultimately, saving more lives by improving the overall effectiveness and efficiency of infection control measures across NHS and private hospitals.
Impact of Products/Services on Healthcare:
Xinix products offer a game-changing approach to infection control in the UK healthcare sector, boasting greater efficiency than traditional disinfectants. This allows for a more secure environment with less effort than previously required.
With Xinix products:
• Legionella will be effectively eliminated from water systems.
• Naked viruses will be reliably inactivated on surfaces.
• The management of multi-resistant bacteria becomes significantly easier.
• Our products are more effective than chlorine-based alternatives and are non-carcinogenic, ensuring both safety and sustainability in UK hospitals and healthcare settings.
Xinix transforms how infection risks are handled, safeguarding lives.
Innovation
Innovation is at the core of Xinix’s approach to advancing healthcare solutions. A recent addition to our growing user base is dental practices. For dentists, we now offer a specialised dosing system for dental chairs and units. The water flushed through these units often has a high organic content, leading to significant biofilm buildup in the pipes, which poses a risk of contamination. Biofilm consists of bacteria and organic matter, a potential threat to patient safety.
Xinix’s products effectively eliminate biofilm in any water system by continuously dosing low levels of our product, ensuring a safer and cleaner environment for dental practices.
Future Direction
Xinix Global AB is committed to becoming the trusted partner of choice within UK healthcare, focusing on the future of disinfection solutions for hospitals and care facilities. Our goal is to address all disinfection needs, from surface sanitation to water systems and medical equipment. As we continue to innovate and advance our product range, we aim to support the NHS and private hospitals with more effective, sustainable, and cost-efficient solutions. By aligning with the healthcare sector’s evolving demands, Xinix is shaping the future of infection control and patient safety across the UK.